AI is entering healthcare faster than governance structures can support responsible deployment. Hospitals, payers, pharmaceutical companies, and digital health organizations are introducing AI into clinical and operational settings without sufficiently involving patients in decision-making. A healthcare executive and attorney advocates for a Chief Patient Officer role to ensure patient representation in leadership and governance. Patient engagement has improved outcomes in clinical trials and healthcare innovation, and patient inclusion strengthens recruitment and the relevance of studies. Patient-informed trial design can improve enrollment efficiency, support patient-focused endpoints, and advance health equity. Patient involvement can also improve clinical adoption and acceptance by health assessors and payers, but governance must evolve further to include patients in leadership roles.
"Artificial intelligence is entering healthcare at a pace that, according to Donna R. Cryer, risks outpacing the governance structures needed to support it responsibly. Cryer believes hospitals, payers, pharmaceutical companies, and digital health organizations are introducing AI systems into clinical and operational environments without sufficiently involving the people most affected by those decisions, which are the patients."
"Cryer believes the healthcare industry now faces an important choice. Leaders can either repeat longstanding mistakes tied to excluding patients from major healthcare decisions, or they can use the emergence of AI as an opportunity to build governance structures correctly from the beginning. She advocates for a Chief Patient Officer role to ensure patient representation in leadership and governance."
"We have seen the benefits of engaging patients. But actually having patients in leadership roles is the next frontier. Cryer points to the evolution of patient engagement across clinical trials and healthcare innovation as evidence that patient involvement improves outcomes. According to her, pharmaceutical companies and health systems have increasingly recognized that patient inclusion strengthens recruitment strategies and the overall relevance of clinical studies."
"Research has shown that patient-informed trial design can improve enrollment efficiency and lead to more patient-focused endpoints, helping achieve health equity. These efforts have also shown to improve enrolment efficacy, improve clinical adoption, while improving acceptance by health assessors and payers."
Read at TNW | Artificial-Intelligence
Unable to calculate read time
Collection
[
|
...
]